Page 8 - Insulin Value Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Adults with diabetes with commercial health insurance who use insulin manufactured by Eli Lilly and Company will have out-of-pocket costs capped at $35 per month, according to a company press release. Effective immediately, Lilly announced it will cap the out-of-pocket cost of insulin at $35 per month for U.S. residents with commercial insurance, as well those without health insurance, through

Eli Lilly announced a series of price cuts on Wednesday that would reduce the price of the most commonly used forms of its insulin by 70%, as well as an automatic cap on out-of-pocket insulin costs at $35 for people with private insurance who use participating pharmacies

Eli Lilly & Company announced cost reductions of up to 70% of its most commonly prescribed insulins today, saying it is committed to making sure its life-saving drugs are “safe, reliable and affordable” to people who rely on them. 

The announcement comes after waves of criticism from Americans saying the drug, which is vital to many people with diabetes, should be more accessible.

ABC57 News in South Bend, Ind. covers all of Michiana including St. Joseph, Elkhart, Kosciusko, LaPorte and Marshall counties in Indiana and Berrien, Cass, Van Buren and St. Joseph counties in Mich.